Thermo Fisher Scientific Inc holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 126,150 | $62,772,240 | 3.33% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 150,450 | $61,001,457 | 3.28% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 150,450 | $72,971,259 | 3.96% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 10, 2025 |
| Dec. 31, 2025 | 134,950 | $78,196,778 | 4.64% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 121,000 | $59,475,130 | 4.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 115,200 | $57,756,672 | 4.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.